Two breathing support methods after heart surgery in infants with congenital heart disease
Compares two breathing supports after tube removal in infants with congenital heart disease.
Key facts
- Who runs it
- Emory University
- Where
- Atlanta, United StatesSee the site
- Trial code
- Registry title
- HFNC vs NIPPV Following Extubation
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 27 Feb 2025
- Expected to end
- Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- High Flow Nasal Canula following extubation
- Non-Invasive Positive Pressure Ventilation following extubation
- Record updated
- 14 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for babies who had heart surgery for a heart problem present from birth (congenital heart disease). It compares two ways to support breathing after the breathing tube is removed.
- Age
- Up to 1 year of age, and/or weight up to 10 kg (22 lb)
- Sex
- All sexes
- Disease stage
- Babies admitted to the cardiac intensive care unit after heart surgery for congenital heart disease.
- Earlier treatment
- Must have had heart surgery for congenital heart disease. Babies who had a tracheostomy (breathing hole in the neck) before the surgery cannot join.
Main reasons for not taking part
- Breathing tube still in place for 4 weeks or more
- Needed ECMO (a heart-lung machine) before surgery
- Birth weight under 2 Kg (4 lb) or born before 35 weeks of pregnancy
- Problems outside the heart that are more than minor
- Taking part in a competing research study
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- All patients admitted to the CICU following cardiac surgery for CHD who are </= 1 year of age and/or weight </= 10 kg
Who cannot take part
- Patients who have a tracheostomy prior to their cardiac surgery
- Gestational age < 35 weeks at birth
- Patients who remain intubated for >/= 4 weeks
- Patient enrolled in a competing research study
- Patients requiring extracorporeal membrane oxygenation (ECMO) support preoperatively
- Patients with birth weight < 2 Kg
- Patients with extracardiac anomalies more than minor severity
Where in United States
- Arthur M Blank Hospital - Children's Healthcare of AtlantaAtlanta, United StatesContact: Asaad Beshish, MDTaking people
About the trial
What the trial wants to find out
This study has the goal to determine the best method of respiratory support following extubation after cardiac surgery (CS). After cardiac surgery for Congenital Heart Disease (CHD), patients remain intubated until the cardiac team determines it is safe for the patient to undergo a trial of extubation. Two common methods of respiratory support following extubation are High Flow Nasal Cannula (HFNC) and Non Invasive Positive Pressure Ventilation (NIPPV). There is currently a gap in data comparing High Flow Nasal Cannula and Non-Invasive Positive Pressure Ventilation in infants (age 0-1) in regard to extubation failure and overall outcomes.
Read full original descriptionShow less
This study will monitor the health outcomes of 200 infants (0 - 1 year) with CHD following cardiac surgery in the Cardiac Intensive Care Unit (CICU) at Children's Healthcare of Atlanta (CHOA). This will be done by assigning the respiratory support method each child will receive following extubation after cardiac surgery. Health outcomes will be monitored until discharge or until the second instance of extubation failure.
Both study arms are standard-of-care respiratory support methods in the CHOA CICU. The investigators aim to determine which of these two methods has fewer risk factors when used with infants.
The 2 groups in the trial
- The high-flow nasal cannula (HFNC)Existing treatment, for comparison
The high flow nasal cannula (HFNC) is a unique mode of respiratory support that delivers warmed, humidified oxygen with a wide range of fractions of inspired oxygen (FiO2) and flow rate (liters/min) without an invasive device such as an endotracheal tube (breathing tube).
Treatment: High Flow Nasal Canula following extubation
- Non-invasive positive pressure ventilation (NIPPV)Existing treatment, for comparison
Non-invasive positive pressure ventilation (NPPV or NIPPV) is a unique mode of respiratory support that delivers pressurized, oxygen-enriched gas to the airway via the nose and/or oropharynx without a more invasive device such as an endotracheal tube (breathing tube).
Treatment: Non-Invasive Positive Pressure Ventilation following extubation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- High Flow Nasal Cannula and Non-Invasive Positive Pressure Ventilation Following Extubation in Infants After Cardiac Surgery for Congenital Heart Disease: A Randomized Clinical Trial
- Plain-language title
- Two breathing support methods after heart surgery in infants with congenital heart diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 14 July 2026